Overview of 2024

2024 represented a year of leadership change at medmix. Strengthening our management team, René Willi was appointed Chief Executive Officer effective June 1, 2024 as Girts Cimermans stepped down from his role. With this leadership transition, earlier in the year, we communicated our commitment to shift gears and transition to a new era of profitable growth and customer centricity. We are pleased to share the progress we have made towards achieving our ambitious goals focused on solutions that help millions of people live healthier and more confident lives.

We have refined our strategy to create a sound foundation for our future growth. Our strategic priorities focus on the adaptation of our organizational setup and the enhancement of our customer proximity and innovation capabilities. To enable this transformation, we have strengthened our business units mirroring the markets and empowered the organization to support a flawless customer experience. We have initiated a comprehensive organizational adaptation, simplifying reporting structures and reducing complexity in the regions. These changes allow us to become faster and more agile.

The launch of a Growth and Efficiency program in the third quarter aims to align our cost structure with our strategic priorities. We will reduce costs and enhance operational efficiency, enabling us to reallocate our resources to high-priority growth areas. The resulting reduction, concentrated in our headquarter and group functions workforce is regrettable and we are taking measures to support affected staff.

Changes to Board of Directors and Executive Committee

When starting his new role as CEO in June 2024, René Willi stepped down as board member and member of the Audit Committee.

At the Annual General Meeting in April 2024, Susanne Hundsbaek-Pedersen was appointed as member of the medmix’ Board of Directors and member of the Audit Committee. Greg Poux-Guillaume did not stand for re-election as a board member. With these changes, the Board of Directors continues to be well prepared for the future.

We are confident that planned operational measures, combined with the dedication of our Executive Committee, the Board of Directors and our employees will position us for sustained growth and success in the long term.

Ongoing support of shareholders is invaluable to us and as always, we are committed to transparency and open communication with all our stakeholders. As to this, in the following you will find our Compensation Report for financial year 2024.